OHCS (Optimus Healthcare Svcs) YoY EBITDA Growth: 2.94% (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Optimus Healthcare Svcs YoY EBITDA Growth?

Optimus Healthcare Svcs OHCS YoY EBITDA Growth is 2.94% as of Sep. 2024.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Optimus Healthcare Svcs's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 2.94%.

Optimus Healthcare Svcs's EBITDA per Share for the three months ended in Sep. 2024 was $-0.03.

Optimus Healthcare Svcs YoY EBITDA Growth Related Terms

Optimus Healthcare Svcs YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Optimus Healthcare Svcs's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optimus Healthcare Svcs YoY EBITDA Growth Chart

Optimus Healthcare Svcs Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec08 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 50.35 -9.39

Optimus Healthcare Svcs Quarterly Data
Sep03 Mar07 Jun07 Sep07 Mar08 Jun08 Sep08 Dec08 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.25 -922.22 109.38 55.74 2.94

Optimus Healthcare Svcs YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Optimus Healthcare Svcs's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.233--0.213)/ | -0.213 |
=-9.39 %

Optimus Healthcare Svcs's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (Q: Sep. 2024 )
=(EBITDA per Share (Q: Sep. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(-0.033--0.034)/ | -0.034 |
=2.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 2.94% mean?
Optimus Healthcare Svcs (OHCS) has a YoY EBITDA Growth of 2.94% as of Sep. 2024. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Optimus Healthcare Svcs and its competitors.
Is Optimus Healthcare Svcs' YoY EBITDA Growth too high?
Optimus Healthcare Svcs' current YoY EBITDA Growth is 2.94%.
How does Optimus Healthcare Svcs' YoY EBITDA Growth compare to FOXO and OTRKQ?
Optimus Healthcare Svcs' YoY EBITDA Growth of 2.94% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Optimus Healthcare Svcs and its competitors. Optimus Healthcare Svcs's current YoY EBITDA Growth is 2.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimus Healthcare Svcs stock overvalued right now?
Optimus Healthcare Svcs (OHCS) has a current YoY EBITDA Growth of 2.94%. The current YoY EBITDA Growth is 2.94%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Optimus Healthcare Svcs (OHCS), the current YoY EBITDA Growth is 2.94% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Optimus Healthcare Svcs Business Description

Address 1400 Old Country Road, Suite 306, Westbury, NY, USA, 11590
Optimus Healthcare Svcs Inc focuses on acquiring controlling interests in healthcare-related businesses. The company is dedicated to advancing access to clinical trial research and simplifying access to vaccines and pharmaceutical products. It currently operates through its portfolio companies, Clinical Research Alliance, Inc. (CRA), and Worker's Health Rx (d/b/a "Vitality Rx"). The vision is to grow by acquiring controlling interests in healthcare-related businesses with products and services that improve healthcare access and outcomes. Optimus aims to empower physicians and patients with information and tools for informed healthcare decisions.